Varroa and Colony Collapse: What the Latest Research Shows

The 2024-25 USDA winter colony loss survey showed 37% national losses, with varroa identified as a contributing factor in 60% of those lost colonies. That number has been remarkably consistent across recent survey years, which tells us something important: the knowledge gap isn't the problem. Most beekeepers know varroa causes colony loss. The gap is between knowing and doing, between understanding the threat and actually running alcohol washes on schedule.

Research updates matter because they refine how we understand the problem and, more practically, whether the management approaches we're using are actually working.

TL;DR

This guide covers key aspects of varroa and colony collapse: what the latest research shows
Mite monitoring should happen at minimum every 3-4 weeks during active season
The 2% threshold in spring/summer and 1% in fall are standard action points based on HBHC guidelines
Always run a pre-treatment and post-treatment mite count to calculate efficacy
Treatment records including product name, EPA number, dates, and counts are required for state inspection compliance
VarroaVault stores all monitoring and treatment data with automatic threshold comparison and state export formatting

What the Latest Research Shows

The USDA-AMS Annual Honey Bee Health Survey

The USDA's annual honey bee survey is the most comprehensive dataset on US colony losses. The 2024-25 data is now part of VarroaVault's updated research database. Key findings:

37% winter loss rate nationally. This is slightly elevated compared to the 5-year average of around 30-34%. Varroa was the primary pest identified in the majority of lost colonies, consistent with all previous survey years.

Geographic variation is pronounced. States with higher beekeeper participation in mite management programs, particularly those with active extension programs and treatment demonstration initiatives, show meaningfully lower loss rates than states with lower participation.

Commercial operations vs. backyard beekeepers. Somewhat counterintuitively, commercial operations often report lower loss rates than smaller hobbyist operations in the same regions. The reason is systematic: commercial beekeepers have economic incentives to maintain rigorous monitoring programs. A hobbyist who loses two hives out of four has a 50% loss rate. A commercial operation that loses 30 of 1,000 hives has 3%.

DWV Strain Evolution

Recent research has documented the spread of DWV strain B (DWV-B, also called VDV-1 or Varroa destructor virus-1) in US bee populations. DWV-B appears to be more virulent than DWV-A and has been displacing DWV-A in populations over recent years.

The practical implication: even mite loads that historically caused subclinical viral expression may produce more visible DWV symptoms as DWV-B becomes the dominant strain. This is one reason why researchers and extension specialists continue to recommend treating at the 2% threshold rather than a higher number. The viral landscape has changed.

Mite Population Genetics and Resistance

Research on varroa population genetics continues to document resistance development in amitraz (the active ingredient in Apivar) in some US populations. Resistance isn't uniform geographically, and not all resistance observations result in clinical treatment failure, but the trend toward reduced amitraz efficacy in some areas is documented.

The extension of this finding for practical management: treatment rotation between active ingredient classes is more important than it was 10 years ago. Relying on a single treatment product every cycle, particularly amitraz, creates selection pressure that regional resistance data confirms is resulting in reduced efficacy in some areas.

Queen Damage Research

A 2023-2024 research program examining varroa damage specifically to developing queens confirmed what empirical observation had long suggested. Colonies with mite loads above 3-4% during the queen development period produced queens with measurably lower vitellogenin levels, reduced egg-laying capacity in the first 30 days, and higher rates of early supersedure.

This research has direct management implications: protecting queen quality means protecting the environment in which queens develop, which means controlling mite loads not just at the threshold but at lower levels during periods of active queen rearing.

The Management Gap: Knowing vs. Doing

The research consistently shows that beekeepers who actually implement scheduled monitoring and threshold-based treatment have dramatically better colony survival outcomes than those who treat on instinct or on a fixed calendar without mite count guidance.

A survey of beekeepers with below-average loss rates consistently found three common behaviors:

They monitored on a scheduled calendar (not on suspicion)
They used threshold counts, not calendar-based treatment triggers
They verified treatment efficacy with post-treatment counts

These are not complex practices. They're accessible to any beekeeper. The gap between knowing about them and actually implementing them is primarily a systems problem: without a reminder, a structured logging workflow, and automatic threshold alerts, the scheduled monitoring gets missed.

This is where management software changes the outcome. Not through any novel knowledge about varroa biology, but by ensuring that the knowledge beekeepers already have gets translated into action at the right moments.

What Research Says About the Future

Colony loss research consistently reinforces two long-term trends:

Resistance management will become more critical. Varroa's capacity for rapid selection means treatment resistance is an ongoing and accelerating challenge. The research community continues to study alternative active ingredients and delivery methods, but none are currently in final regulatory stages. For the next 5-10 years, responsible rotation of currently registered products remains the primary resistance management tool.

Genetic resistance is gaining traction. VSH and hygienic breeding programs continue to show strong results. Large-scale adoption of resistant genetics remains limited by economic factors (resistant queens cost more) and practical factors (maintaining genetic integrity in open-mating environments is difficult). But the research supports that genetic management is the most sustainable long-term path, and early adopters in commercial operations are documenting real reductions in treatment frequency.

VarroaVault connects your individual colony outcomes to these population-level research findings through the complete varroa management guide. Your count data and treatment outcomes are your local data contribution to understanding what's working in your specific conditions. And the winter survival guide connects research findings on fall treatment timing directly to your August count decisions.

Frequently Asked Questions

What does the latest research say about varroa and colony collapse?

The 2024-25 USDA winter colony loss survey showed 37% national losses, with varroa implicated in 60% of those losses. This is consistent with several years of survey data. Recent research has also documented the spread of more virulent DWV strain B in US bee populations, increasing the virus load consequences of mite infestations. Resistance development in amitraz has been confirmed in some regional populations, reinforcing the importance of treatment rotation. The research consistently shows that beekeepers who monitor on schedule and treat at threshold have meaningfully lower colony loss rates than those who manage reactively.

Has colony loss rate improved with better varroa management tools?

Progress has been mixed. National average loss rates have declined somewhat from the peaks of the 2007-2012 period, but remain substantially elevated compared to pre-varroa historical averages of 10-15% winter losses. Beekeepers using systematic threshold-based management programs show loss rates well below the national average. The challenge is that widespread adoption of rigorous monitoring remains limited. The proportion of beekeepers regularly doing alcohol washes and responding to threshold crossings is still a minority of total beekeepers nationally.

How does VarroaVault help beekeepers act on the latest research?

VarroaVault's research citations are updated annually, with the 2026 edition incorporating the latest USDA-AMS honey bee health survey data and recent resistance monitoring findings. The platform's monitoring calendar implements the research-backed testing frequency recommendations. Threshold settings reflect current HBHC recommendations adjusted for season and colony type. Treatment rotation tracking implements resistance management protocols supported by population genetics research. And the efficacy scoring system flags potential resistance development when post-treatment counts consistently underperform the 90%+ efficacy benchmark. Research findings are built into the management workflow rather than presented as background reading.

How do I know if my varroa treatment is working?

Run a mite count 2-4 weeks after the treatment ends and compare it to your pre-treatment count. The efficacy formula is: ((pre-count - post-count) / pre-count) x 100. A result above 90% indicates effective treatment. Results below 80% should trigger investigation for possible resistance, application error, or reinfestation. Log both counts in VarroaVault to track efficacy trends across treatment cycles.

How often should I check mite levels in my hives?

At minimum, once per month (every 3-4 weeks) during the active season. Increase to every 2 weeks when counts are near threshold or after a treatment to verify it worked. In fall, monitoring frequency matters most because the window to treat before winter bees are raised is narrow. VarroaVault's monitoring reminders can be set to your preferred interval for each apiary.

What records should I keep for varroa management?

Each record should include: date of count or treatment, hive identifier, monitoring method used, number of bees sampled, mites counted, infestation percentage, treatment product name and EPA registration number, dose applied, treatment start and end dates, and PHI end date. State apiarists typically expect this level of detail during inspections. VarroaVault captures all of these fields in a single log entry.

Sources

American Beekeeping Federation (ABF)
USDA ARS Bee Research Laboratory
Honey Bee Health Coalition
Penn State Extension Apiculture Program
Project Apis m.

Get Started with VarroaVault

The information in this guide is most useful when you have your own mite count data to apply it to. VarroaVault stores every count, flags threshold crossings automatically, and builds the treatment history you need for state inspections and effective management decisions. Start your free trial at varroavault.com.